stopping glp 1 weight gain The Data Are Clear: Patients Regain After GLP-1 Drugs A Practical Guide to GLP-1

Diabetologia 58:26372646 van Bloemendaal L, Ten Kulve JS, la Fleur SE et al (2014) Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS

The FDA prescribing information does not contraindicate tirzepatide in patients who have undergone gallbladder removal, and the medication's effectiveness is not affected by gallbladder status

Who Is a Good Candidate for Tirzepatide

PC=Placebo An RCT of nondiabetic patients (N = 1961)1: After 68 weeks, mean weight loss was 15% (15 kg) versus 2% (3 kg) PC

With all the buzz around these medications, it's natural to ask: who is eligible for GLP-1 medications, and could you be a candidate